{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:56:37Z","timestamp":1790283397475,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T00:00:00Z","timestamp":1693785600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T00:00:00Z","timestamp":1693785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01 DK061034"],"award-info":[{"award-number":["U01 DK061034"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["P30DK097512"],"award-info":[{"award-number":["P30DK097512"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK057846"],"award-info":[{"award-number":["R01DK057846"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK121929"],"award-info":[{"award-number":["R01DK121929"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK129523"],"award-info":[{"award-number":["R01DK129523"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK133881"],"award-info":[{"award-number":["R01DK133881"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01 DK061010"],"award-info":[{"award-number":["U01 DK061010"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01 DK061042"],"award-info":[{"award-number":["U01 DK061042"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01 DK061058"],"award-info":[{"award-number":["U01 DK061058"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01 DK085453"],"award-info":[{"award-number":["U01 DK085453"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01 DK085461"],"award-info":[{"award-number":["U01 DK085461"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01 DK085465"],"award-info":[{"award-number":["U01 DK085465"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01 DK085466"],"award-info":[{"award-number":["U01 DK085466"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01 DK085476"],"award-info":[{"award-number":["U01 DK085476"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01 DK085499"],"award-info":[{"award-number":["U01 DK085499"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01 DK085504"],"award-info":[{"award-number":["U01 DK085504"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01 DK085509"],"award-info":[{"award-number":["U01 DK085509"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01 DK103153"],"award-info":[{"award-number":["U01 DK103153"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01 DK103180"],"award-info":[{"award-number":["U01 DK103180"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01 DK103266"],"award-info":[{"award-number":["U01 DK103266"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01 DK103282"],"award-info":[{"award-number":["U01 DK103282"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01 DK106984"],"award-info":[{"award-number":["U01 DK106984"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01 DK106994"],"award-info":[{"award-number":["U01 DK106994"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01 DK107013"],"award-info":[{"award-number":["U01 DK107013"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01 DK107014"],"award-info":[{"award-number":["U01 DK107014"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01DK127382"],"award-info":[{"award-number":["U01DK127382"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["UC4 DK097835"],"award-info":[{"award-number":["UC4 DK097835"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["UC4 DK106993"],"award-info":[{"award-number":["UC4 DK106993"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000925","name":"John Templeton Foundation","doi-asserted-by":"publisher","award":["62288"],"award-info":[{"award-number":["62288"]}],"id":[{"id":"10.13039\/100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000901","name":"Juvenile Diabetes Research Foundation International","doi-asserted-by":"publisher","award":["SRA-2019-833-S-B"],"award-info":[{"award-number":["SRA-2019-833-S-B"]}],"id":[{"id":"10.13039\/100000901","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s00125-023-06003-5","type":"journal-article","created":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T17:01:47Z","timestamp":1693846907000},"page":"2283-2291","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["High proinsulin:C-peptide ratio identifies individuals with stage 2 type 1 diabetes at high risk for progression to clinical diagnosis and responses to teplizumab treatment"],"prefix":"10.1007","volume":"66","author":[{"given":"Emily K.","family":"Sims","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Geyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Alice","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevan C.","family":"Herold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,4]]},"reference":[{"key":"6003_CR1","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1016\/S0140-6736(18)31320-5","volume":"391","author":"LA DiMeglio","year":"2018","unstructured":"DiMeglio LA, Evans-Molina C, Oram RA (2018) Type 1 diabetes. Lancet 391:2449\u20132462. https:\/\/doi.org\/10.1016\/S0140-6736(18)31320-5","journal-title":"Lancet"},{"key":"6003_CR2","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/MED.0000000000000548","volume":"27","author":"EK Sims","year":"2020","unstructured":"Sims EK, Mirmira RG, Evans-Molina C (2020) The role of beta-cell dysfunction in early type 1 diabetes. Curr Opin Endocrinol Diabetes Obes 27:215\u2013224. https:\/\/doi.org\/10.1097\/MED.0000000000000548","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"6003_CR3","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.tem.2011.02.008","volume":"22","author":"SG Fonseca","year":"2011","unstructured":"Fonseca SG, Gromada J, Urano F (2011) Endoplasmic reticulum stress and pancreatic \u03b2-cell death. Trends Endocrinol Metab 22:266\u2013274. https:\/\/doi.org\/10.1016\/j.tem.2011.02.008","journal-title":"Trends Endocrinol Metab"},{"key":"6003_CR4","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1007\/s00125-015-3669-6","volume":"58","author":"F Brozzi","year":"2015","unstructured":"Brozzi F, Nardelli TR, Lopes M et al (2015) Cytokines induce endoplasmic reticulum stress in human, rat and mouse beta cells via different mechanisms. Diabetologia 58:2307\u20132316. https:\/\/doi.org\/10.1007\/s00125-015-3669-6","journal-title":"Diabetologia"},{"key":"6003_CR5","doi-asserted-by":"publisher","first-page":"756548","DOI":"10.3389\/fimmu.2021.756548","volume":"12","author":"E Toren","year":"2021","unstructured":"Toren E, Burnette KS, Banerjee RR, Hunter CS, Tse HM (2021) Partners in crime: beta-cells and autoimmune responses complicit in type 1 diabetes pathogenesis. Front Immunol 12:756548. https:\/\/doi.org\/10.3389\/fimmu.2021.756548","journal-title":"Front Immunol"},{"key":"6003_CR6","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.2337\/db18-0279","volume":"67","author":"T Mezza","year":"2018","unstructured":"Mezza T, Ferraro PM, Sun VA et al (2018) Increased \u03b2-cell workload modulates proinsulin-to-insulin ratio in humans. Diabetes 67:2389\u20132396. https:\/\/doi.org\/10.2337\/db18-0279","journal-title":"Diabetes"},{"issue":"5","key":"6003_CR7","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.2337\/dbi20-0034","volume":"70","author":"T Rodriguez-Calvo","year":"2021","unstructured":"Rodriguez-Calvo T, Chen YC, Verchere CB et al (2021) Altered \u03b2-cell prohormone processing and secretion in type 1 diabetes. Diabetes 70(5):1038\u20131050. https:\/\/doi.org\/10.2337\/dbi20-0034","journal-title":"Diabetes"},{"key":"6003_CR8","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.2337\/dc15-2849","volume":"39","author":"EK Sims","year":"2016","unstructured":"Sims EK, Chaudhry Z, Watkins R et al (2016) Elevations in the fasting serum proinsulin-to-c-peptide ratio precede the onset of type 1 diabetes. Diabetes Care 39:1519\u20131526. https:\/\/doi.org\/10.2337\/dc15-2849","journal-title":"Diabetes Care"},{"key":"6003_CR9","doi-asserted-by":"publisher","first-page":"e0166702","DOI":"10.1371\/journal.pone.0166702","volume":"11","author":"A Van Dalem","year":"2016","unstructured":"Van Dalem A, Demeester S, Balti EV et al (2016) Prediction of impending type 1 diabetes through automated dual-label measurement of proinsulin:C-peptide ratio. PLoS One 11:e0166702. https:\/\/doi.org\/10.1371\/journal.pone.0166702","journal-title":"PLoS One"},{"key":"6003_CR10","doi-asserted-by":"publisher","first-page":"818","DOI":"10.2337\/db11-1293","volume":"61","author":"SA Tersey","year":"2012","unstructured":"Tersey SA, Nishiki Y, Templin AT et al (2012) Islet \u03b2-cell endoplasmic reticulum stress precedes the onset of type 1 diabetes in the nonobese diabetic mouse model. Diabetes 61:818\u2013827. https:\/\/doi.org\/10.2337\/db11-1293","journal-title":"Diabetes"},{"key":"6003_CR11","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.trsl.2019.08.001","volume":"213","author":"EK Sims","year":"2019","unstructured":"Sims EK, Syed F, Nyalwidhe J et al (2019) Abnormalities in proinsulin processing in islets from individuals with longstanding T1D. Transl Res 213:90\u201399. https:\/\/doi.org\/10.1016\/j.trsl.2019.08.001","journal-title":"Transl Res"},{"issue":"5","key":"6003_CR12","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.2337\/db16-1343","volume":"66","author":"T Rodriguez-Calvo","year":"2017","unstructured":"Rodriguez-Calvo T, Zapardiel-Gonzalo J, Amirian N et al (2017) Increase in pancreatic proinsulin and preservation of \u03b2-cell mass in autoantibody-positive donors prior to type 1 diabetes onset. Diabetes 66(5):1334\u20131345. https:\/\/doi.org\/10.2337\/db16-1343","journal-title":"Diabetes"},{"key":"6003_CR13","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1056\/NEJMoa1902226","volume":"381","author":"KC Herold","year":"2019","unstructured":"Herold KC, Bundy BN, Long SA et al (2019) An anti-CD3 antibody, teplizumab, in relatives at risk for type 1 diabetes. N Engl J Med 381:603\u2013613. https:\/\/doi.org\/10.1056\/NEJMoa1902226","journal-title":"N Engl J Med"},{"issue":"12","key":"6003_CR14","doi-asserted-by":"publisher","first-page":"2922","DOI":"10.2337\/db21-0519","volume":"70","author":"EK Sims","year":"2021","unstructured":"Sims EK, Cuthbertson D, Herold KC, Sosenko JM (2021) The deterrence of rapid metabolic decline within 3 months after teplizumab treatment in individuals at high risk for type 1 diabetes. Diabetes 70(12):2922\u20132931. https:\/\/doi.org\/10.2337\/db21-0519","journal-title":"Diabetes"},{"key":"6003_CR15","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.2337\/dc19-0593","volume":"42","author":"EK Sims","year":"2019","unstructured":"Sims EK, Geyer S, Johnson SB et al (2019) Who is enrolling? The path to monitoring in type 1 diabetes TrialNet\u2019s Pathway to Prevention. Diabetes Care 42:2228\u20132236. https:\/\/doi.org\/10.2337\/dc19-0593","journal-title":"Diabetes Care"},{"issue":"583","key":"6003_CR16","doi-asserted-by":"publisher","first-page":"eabc8980","DOI":"10.1126\/scitranslmed.abc8980","volume":"13","author":"EK Sims","year":"2021","unstructured":"Sims EK, Bundy BN, Stier K et al (2021) Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals. Sci Transl Med 13(583):eabc8980. https:\/\/doi.org\/10.1126\/scitranslmed.abc8980","journal-title":"Sci Transl Med"},{"key":"6003_CR17","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1007\/s00125-020-05115-6","volume":"63","author":"P Leete","year":"2020","unstructured":"Leete P, Oram RA, McDonald TJ et al (2020) Studies of insulin and proinsulin in pancreas and serum support the existence of aetiopathological endotypes of type 1 diabetes associated with age at diagnosis. Diabetologia 63:1258\u20131267. https:\/\/doi.org\/10.1007\/s00125-020-05115-6","journal-title":"Diabetologia"},{"key":"6003_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.cellimm.2017.07.007","volume":"319","author":"SA Long","year":"2017","unstructured":"Long SA, Thorpe J, Herold KC et al (2017) Remodeling T cell compartments during anti-CD3 immunotherapy of type 1 diabetes. Cell Immunol 319:3\u20139. https:\/\/doi.org\/10.1016\/j.cellimm.2017.07.007","journal-title":"Cell Immunol"},{"key":"6003_CR19","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.4049\/jimmunol.158.6.2947","volume":"158","author":"L Chatenoud","year":"1997","unstructured":"Chatenoud L, Primo J, Bach JF (1997) CD3 antibody-induced dominant self tolerance in overtly diabetic NOD mice. J Immunol 158:2947\u20132954. https:\/\/doi.org\/10.4049\/jimmunol.158.6.2947","journal-title":"J Immunol"},{"key":"6003_CR20","doi-asserted-by":"publisher","first-page":"3901","DOI":"10.2337\/db13-0236","volume":"62","author":"W Hagopian","year":"2013","unstructured":"Hagopian W, Ferry RJ Jr, Sherry N et al (2013) Teplizumab preserves C-peptide in recent-onset type 1 diabetes: two-year results from the randomized, placebo-controlled Protege trial. Diabetes 62:3901\u20133908. https:\/\/doi.org\/10.2337\/db13-0236","journal-title":"Diabetes"},{"key":"6003_CR21","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1056\/NEJMoa2006136","volume":"383","author":"T Quattrin","year":"2020","unstructured":"Quattrin T, Haller MJ, Steck AK et al (2020) Golimumab and beta-cell function in youth with new-onset type 1 diabetes. N Engl J Med 383:2007\u20132017. https:\/\/doi.org\/10.1056\/NEJMoa2006136","journal-title":"N Engl J Med"},{"key":"6003_CR22","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.trsl.2015.08.010","volume":"168","author":"RA Watkins","year":"2016","unstructured":"Watkins RA, Evans-Molina C, Terrell JK et al (2016) Proinsulin and heat shock protein 90 as biomarkers of beta-cell stress in the early period after onset of type 1 diabetes. Transl Res 168:96\u2013106. https:\/\/doi.org\/10.1016\/j.trsl.2015.08.010","journal-title":"Transl Res"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-023-06003-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00125-023-06003-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-023-06003-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T19:03:36Z","timestamp":1725390216000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00125-023-06003-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,4]]},"references-count":22,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["6003"],"URL":"https:\/\/doi.org\/10.1007\/s00125-023-06003-5","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,4]]},"assertion":[{"value":"22 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Data are available upon reasonable request to the authors or via submission request via\n                      \n                      .","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"The Type 1 Diabetes TrialNet Study Group is a clinical trials network funded by the National Institutes of Health (NIH) through the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the National Institute of Allergy and Infectious Diseases, and the Eunice Kennedy Shriver National Institute of Child Health and Human Development, through cooperative agreements U01 DK061010, U01 DK061034, U01 DK061042, U01 DK061058, U01 DK085465, U01 DK085453, U01 DK085461, U01 DK085466, U01 DK085499, U01 DK085504, U01 DK085509, U01 DK103180, U01 DK103153, U01 DK085476, U01 DK103266, U01 DK103282, U01 DK106984, U01 DK106994, U01 DK107013, U01 DK107014, UC4 DK097835, and UC4 DK106993, and JDRF. EKS receives support from NIH grants R01DK121929, R01DK133881 and U01DK127382-012. EKS was also supported by the Doris Duke Charitable Foundation (grant 2021258) through the COVID-19 Fund to Retain Clinical Scientists collaborative grant programme, and by the John Templeton Foundation (grant 62288). The studies were supported by R01 DK057846 and R01 DK129523 from the NIH, and SRA-2019-833-S-B from JDRF (to KCH). This work utilised core services provided by the Diabetes Research Center grant P30 DK097512 (to Indiana University School of Medicine).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"EKS has received compensation for educational lectures on diabetes screening from Medscape and Health Matters CME. KCH has consulted for Provention Bio and is a co-inventor on a patent application for use of teplizumab for delay of stage 3 type 1 diabetes but without financial remuneration. All other authors declare that there are no relationships or activities that might bias, or be perceived to bias, their work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 relationships and activities"}},{"value":"EKS, SMG and KCH conceived the project, analysed data, obtained funding, and wrote and edited the manuscript. SAL analysed data and edited the manuscript. All authors approved the final version of the manuscript. KCH is responsible for the integrity of the work as a whole.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Contribution statement"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}